IceCure Medical Ltd
ICCM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $850 | $525 | $725 | $875 |
| % Growth | 61.9% | -27.6% | -17.1% | – |
| Cost of Goods Sold | $573 | $394 | $507 | $458 |
| Gross Profit | $277 | $131 | $218 | $417 |
| % Margin | 32.6% | 25% | 30.1% | 47.7% |
| R&D Expenses | $1,762 | $1,711 | $1,664 | $1,695 |
| G&A Expenses | $1,436 | $2,674 | $922 | $992 |
| SG&A Expenses | $2,351 | $1,805 | $2,211 | $3,247 |
| Sales & Mktg Exp. | $915 | -$869 | $1,289 | $2,255 |
| Other Operating Expenses | $14,084 | $0 | $0 | $0 |
| Operating Expenses | $18,197 | $3,516 | $3,875 | $4,942 |
| Operating Income | -$17,920 | -$3,385 | -$3,657 | -$4,525 |
| % Margin | -2,108.2% | -644.8% | -504.4% | -517.1% |
| Other Income/Exp. Net | $14,061 | $21 | $69 | $46 |
| Pre-Tax Income | -$3,859 | -$3,364 | -$3,588 | -$4,479 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,859 | -$3,364 | -$3,588 | -$4,479 |
| % Margin | -454% | -640.8% | -494.9% | -511.9% |
| EPS | -0.059 | -0.057 | -0.062 | -0.081 |
| % Growth | -3% | 7.9% | 22.8% | – |
| EPS Diluted | -0.06 | -0.057 | -0.062 | -0.081 |
| Weighted Avg Shares Out | 63,883 | 58,697 | 57,640 | 55,551 |
| Weighted Avg Shares Out Dil | 65,390 | 58,697 | 57,640 | 55,551 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $21 | $69 | $46 |
| Interest Expense | $23 | $0 | $0 | $0 |
| Depreciation & Amortization | $73 | $62 | $89 | $82 |
| EBITDA | -$3,763 | -$3,323 | -$3,568 | -$4,443 |
| % Margin | -442.7% | -633% | -492.1% | -507.8% |